trending Market Intelligence /marketintelligence/en/news-insights/trending/vHOquZRm7kdhVU7BiXr_XQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

S&P Global Ratings flags NMC Health for possible downgrade

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


S&P Global Ratings flags NMC Health for possible downgrade

S&P Global Ratings flagged NMC Health PLC for a possible downgrade after reports that its largest shareholders sold some of their holdings.

The credit rating agency changed its outlook on NMC Health's BB+ rating to negative, indicating that it could be downgraded in the future. The outlook revision follows a sharp decline in the Middle Eastern healthcare services provider's stock price following a stake sale in the company by Vice Chairman Khaleefa Al Muhairi and second-largest shareholder Saeed Al Qebaisi.

The sale came after a report by U.S. short-selling firm Muddy Waters LLC last month, accusing the company of a number of deficiencies. NMC responded to the report at the time by starting an independent third-party review of its business, though denied any wrongdoing on its part — calling the report false and misleading.

S&P Ratings said the developments are likely to distract day-to-day management and add uncertainty to the company's future direction. The sale in particular can cause a change in the company's board and hence, a change in strategy.

"We believe the allegations and the sale could impair the company's access to financial markets and create additional uncertainty about its future direction and governance," the rating agency said.

In its assessment of the company's business profile, the credit agency said NMC has a strong, long-standing reputation in the Middle East and receives its income from a diverse range of sources, although it is somewhat affected by private- and government-funded health care schemes.

S&P Global Ratings expects NMC to continue making $180 million to $250 million of free operating cash flow in 2020 and 2021, which lines up with the BB+ rating.

The company's rating will be downgraded if the company faces accounting issues, fraudulent activities or big changes to financial expectations in the next yearly results.

S&P Global Ratings may revise the outlook to stable if the independent review deems NMC's accounting problem-free and the company's management is unaffected by recent events. The outlook may also be revised if NMC can generate positive free operating cash flow.

This S&P Global Market Intelligence news article may contain information about credit ratings issued by S&P Global Ratings. Descriptions in this news article were not prepared by S&P Global Ratings.